High Follistatin Predicts Poor Cardiometabolic Outcomes
Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.
Gunnar Engstr Preprints With The Lancet Diet Cancer Study Yang De Marinis Lundoch Diagnostics Diabetes Mellitus Type 2
Source: medscape.com